Public health, justice and chloroquine: pharmacoepidemiology aspects and bioethical reflections about COVID-19 pandemic in Brazil
DOI:
https://doi.org/10.5902/2179378643590Keywords:
COVID-19, Pharmacoepidemiology, Bioethics, Research Ethics, Public HealthAbstract
This article presents a scientific overview about COVID-19 pandemic, discusses bioethical questions which emerge from the current context and assesses possible answers to these questions. Firstly we present medical and pharmacological community's literature on efficient treatments against the disease and then gather public data about public health from Brazilian government websites. Then we investigate (bio)ethical questions about these facts. A short discussion about Beauchamp and Childress' principlism was made. We concluded that some of Brazilian governors’ measures in favor of social isolation are morally justified. It is considered that ongoing clinical pharmacological trials with human beings are morally permissible as long as patient’s autonomy is ensured and risk-benefits analysis is positive. Lastly, we show the relationship between science and philosophy in the ethical, political and biomedical fields.Downloads
References
AZEVEDO, M., DALL’AGNOL, D., BONELLA, A., ARAUJO, M. Por um debate sobre as diretrizes éticas para alocação de tratamento em UTI durante a pandemia. Disponível em: https://estadodaarte.estadao.com.br/amplo-debate-criterios-uti-coronavirus/ Acesso em: 21 jun. 2020.
BARREIRO, E. & MANSOUR, C. Química Medicinal: as bases moleculares da ação dos fármacos. 2ª ed. Porto Alegre: Artmed, 2008.
BIOT, C., DAHER, W., CHAVAIN, N., FANDEUR, T., KHALIFE, J., DIVE, D., CLERCQ, E. Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities. Journal Of Medicinal Chemistry, v. 49, n. 9, p. 2845-2849, maio 2006. http://dx.doi.org/10.1021/jm0601856
BORBA, Mayla et al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase iib clinical trial (clorocovid-19 study). Medrxiv, 11 abr. 2020. Cold Spring Harbor Laboratory. http://dx.doi.org/10.1101/2020.04.07.20056424
BRASIL. Ministério da Saúde. Atualiza informações sobre o Uso da Cloroquina como terapia adjuvante no tratamento de formas graves do COVID-19, ficando revogada a Nota Informativa nº 5/2020-DAF/SCTIE/MS, datada de 27 de março de 2020. Nota Informativa, nº6. Disponível em: https://www.saude.gov.br/images/pdf/2020/April/01/MS---0014223901---Nota-Informativa-n---6-2020-DAF-SCTIE-MS.pdf Acesso em: 12/04/2020.
BRASIL. Ministério da Saúde. Resolução nº466. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html Acesso em: 16/04/2020.
BRASIL. Saiba quais são as principais dúvidas dos cidadãos sobre o Auxílio Emergencial. Disponível em: https://www.gov.br/pt-br/noticias/assistencia-social/2020/04/auxilio-emergencial-covid-19 Acesso em: 12/04/2020.
BRASIL. Sobre a doença COVID-19: como se proteger. Disponível em: https://coronavirus.saude.gov.br/sobre-a-doenca#como-se-proteger Acesso em: 16/04/2020.
CHEN, W. et al. The SARS-CoV-2 Vaccine Pipeline: an overview. Current Tropical Medicine Reports, p. 1-4, 3 mar. 2020. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s40475-020-00201-6
DALL'AGNOL, D. Bioética. Rio de Janeiro: Zahar Editora, 2005.
DALL’AGNOL, D. Neurobioética e políticas públicas para melhoramento cognitivo. In: Crisp, R.; Dall’agnol, D.; Savulescu, J.; Tonetto, M.C. (Orgs.). Ética aplicada de políticas públicas. Florianópolis: Editora UFSC, 2018.
DATASUS. Ministério da Saúde. Disponível em http://www.datasus.gov.br Acesso em 16/04/2020.
DI BLASI, E. Italians over 80 'will be left to die' as country overwhelmed by coronavirus. Hardest-hit region drafts new proposals saying who will live and who will die. Disponível em: https://www.telegraph.co.uk/news/2020/03/14/italians-80-will-left-die-country-overwhelmed-coronavirus/ Acesso em: 08/04/2020.
GAO, J., TIAN, Z.; YANG, X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies. Bioscience Trends, v. 14, n. 1, p. 72-73, 29 fev. 2020. International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA). http://dx.doi.org/10.5582/bst.2020.01047
GAUTRET, Philippe et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial: results of an open-label non-randomized clinical trial. International Journal Of Antimicrobial Agents, mar. 2020. Elsevier BV. http://dx.doi.org/10.1016/j.ijantimicag.2020.105949
GRADY, C. Ethics of vaccine research. In: Iltis, A. S. Research Ethics. Nova Iorque: Routledge, 2006.
GYNGELL, C., DOUGLAS, T., SAVULESCU, J. A ética da edição de genes da linhagem germinativa. In: Crisp, R.; Dall’agnol, D.; Savulescu, J.; Tonetto, M.C. (Orgs.). Ética aplicada de políticas públicas. Florianópolis: Editora UFSC, 2018.
LEWNARD, J. & LO, N. C. Scientific and ethical basis for social-distancing interventions against COVID-19. The Lancet. Infectious diseases, 2020. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118670/ Acesso em: 10/04/2020.
LI, Xiaofan; BURTON, Eric M.; BHADURI-MCINTOSH, Sumita. Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells. Plos Pathogens, v. 13, n. 3, p. 11-12, 1 mar. 2017. Public Library of Science (PLoS). http://dx.doi.org/10.1371/journal.ppat.1006249
LIN, Janet Y.; ANDERSON-SHAW, Lisa. Rationing of resources: ethical issues in disasters and epidemic situations. Prehospital and disaster medicine, v. 24, n. 3, p. 215-221, 2009. https://doi.org/10.1017/s1049023x0000683x
MACEDO, A. V., ROCHA, M. O. C. Infecção pelo vírus Epstein-Barr e Oncogênese. Rev Med Minas Gerais, Minas Gerais, v. 13, n. 4, p. 262-72, 2003
MINISTÉRIO DA SAÚDE. Conselho Nacional de Saúde. Ementa (quando houver). Resolução, nº 466, 12 de dezembro de 2012. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html Acesso em: 16 de abril de 2020.
SANDERS, J. M. et al. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). Jama, 13 abr. 2020. American Medical Association (AMA). http://dx.doi.org/10.1001/jama.2020.6019
SAVARINO, A., BOELAERT, J. R., CASSONE, A.; MAJORI, G., CAUDA, R. Effects of chloroquine on viral infections: an old drug against today's diseases: an old drug against today's diseases. The Lancet Infectious Diseases, v. 3, n. 11, p. 722-727, nov. 2003. Elsevier BV. http://dx.doi.org/10.1016/s1473-3099(03)00806-5
SAVULESCU, J. Is it right to cut corners in the search for a coronavirus cure. Disponível em: https://www.theguardian.com/commentisfree/2020/mar/25/search-coronavirus-cure-vaccine-pandemic Acesso em: 12 abr. 2020.
SINITOX. Sistema Nacional de Informações Tóxico-Farmacológicas. Rio de Janeiro: Fundação Oswaldo Cruz, 2017. Disponível em: https://sinitox.icict.fiocruz.br/dados-nacionais Acesso em: 13/04/2020.
SOHRABI, C. et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus. Int J Surg, v. 76, p. 71-76, abr. 2020. https://doi.org/10.1016/j.ijsu.2020.02.034
WALKER, Patrick GT et al. The global impact of covid-19 and strategies for mitigation and suppression. WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, 2020. Disponível em:
https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Global-Impact-26-03-2020v2.pdf Acesso em: 13/04/2020.
XIAO, Chunfeng. A novel approach of consultation on 2019 novel coronavirus (COVID-19)-related psychological and mental problems: Structured letter therapy. Psychiatry investigation, v. 17, n. 2, p. 175, 2020. Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/32093461 Acesso em: 10/04/2020.
Downloads
Published
How to Cite
Issue
Section
License
The submission of original manuscripts to this journal implies the transference, by the authors, of the copyrights for printed and digital publication. The copyrights of a published manuscript belong ultimately to the author, and only the copyright for its first publication is reserved to the journal. Authors may only use the same results in other publications explicitly indicating this journal as the medium of the original publication.
Licence
Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) - This license lets others remix, tweak, and build upon your work non-commercially, as long as they credit you and license their new creations under the identical terms.
